BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 28530655)

  • 1. A quantitative and multiplexed approach to uncover the fitness landscape of tumor suppression in vivo.
    Rogers ZN; McFarland CD; Winters IP; Naranjo S; Chuang CH; Petrov D; Winslow MM
    Nat Methods; 2017 Jul; 14(7):737-742. PubMed ID: 28530655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mapping the in vivo fitness landscape of lung adenocarcinoma tumor suppression in mice.
    Rogers ZN; McFarland CD; Winters IP; Seoane JA; Brady JJ; Yoon S; Curtis C; Petrov DA; Winslow MM
    Nat Genet; 2018 Apr; 50(4):483-486. PubMed ID: 29610476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo CRISPR screening unveils histone demethylase UTX as an important epigenetic regulator in lung tumorigenesis.
    Wu Q; Tian Y; Zhang J; Tong X; Huang H; Li S; Zhao H; Tang Y; Yuan C; Wang K; Fang Z; Gao L; Hu X; Li F; Qin Z; Yao S; Chen T; Chen H; Zhang G; Liu W; Sun Y; Chen L; Wong KK; Ge K; Chen L; Ji H
    Proc Natl Acad Sci U S A; 2018 Apr; 115(17):E3978-E3986. PubMed ID: 29632194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p16Ink4a suppression of lung adenocarcinoma by Bmi-1 in the presence of p38 activation.
    Lee MO; Lee HJ; Kim MA; Kim EK; Lee JH; Heo JH; Lee SH; Cho SH; Fornace AJ; Jeong HC; Cha HJ
    J Thorac Oncol; 2011 Mar; 6(3):423-31. PubMed ID: 21164364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Functional Taxonomy of Tumor Suppression in Oncogenic KRAS-Driven Lung Cancer.
    Cai H; Chew SK; Li C; Tsai MK; Andrejka L; Murray CW; Hughes NW; Shuldiner EG; Ashkin EL; Tang R; Hung KL; Chen LC; Lee SYC; Yousefi M; Lin WY; Kunder CA; Cong L; McFarland CD; Petrov DA; Swanton C; Winslow MM
    Cancer Discov; 2021 Jul; 11(7):1754-1773. PubMed ID: 33608386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination wt-p53 and MicroRNA-125b Transfection in a Genetically Engineered Lung Cancer Model Using Dual CD44/EGFR-targeting Nanoparticles.
    Talekar M; Trivedi M; Shah P; Ouyang Q; Oka A; Gandham S; Amiji MM
    Mol Ther; 2016 Apr; 24(4):759-69. PubMed ID: 26686386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New syngeneic inflammatory-related lung cancer metastatic model harboring double KRAS/WWOX alterations.
    Bleau AM; Freire J; Pajares MJ; Zudaire I; Anton I; Nistal-Villán E; Redrado M; Zandueta CN; Garmendia I; Ajona D; Blanco D; Pio R; Lecanda F; Calvo A; Montuenga LM
    Int J Cancer; 2014 Dec; 135(11):2516-27. PubMed ID: 24473991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lentiviral vector-mediated RBM5 overexpression downregulates EGFR expression in human non-small cell lung cancer cells.
    Su Z; Yin J; Zhao L; Li R; Liang H; Zhang J; Wang K
    World J Surg Oncol; 2014 Dec; 12():367. PubMed ID: 25441176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the K-ras and p53 pathways in X-ray-induced lung tumors in the rat.
    Belinsky SA; Middleton SK; Picksley SM; Hahn FF; Nikula KJ
    Radiat Res; 1996 Apr; 145(4):449-56. PubMed ID: 8600505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiplexed in vivo homology-directed repair and tumor barcoding enables parallel quantification of Kras variant oncogenicity.
    Winters IP; Chiou SH; Paulk NK; McFarland CD; Lalgudi PV; Ma RK; Lisowski L; Connolly AJ; Petrov DA; Kay MA; Winslow MM
    Nat Commun; 2017 Dec; 8(1):2053. PubMed ID: 29233960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pancreatic cancer modeling using retrograde viral vector delivery and in vivo CRISPR/Cas9-mediated somatic genome editing.
    Chiou SH; Winters IP; Wang J; Naranjo S; Dudgeon C; Tamburini FB; Brady JJ; Yang D; Grüner BM; Chuang CH; Caswell DR; Zeng H; Chu P; Kim GE; Carpizo DR; Kim SK; Winslow MM
    Genes Dev; 2015 Jul; 29(14):1576-85. PubMed ID: 26178787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fully accessible fitness landscape of oncogene-negative lung adenocarcinoma.
    Yousefi M; Andrejka L; Szamecz M; Winslow MM; Petrov DA; Boross G
    Proc Natl Acad Sci U S A; 2023 Sep; 120(38):e2303224120. PubMed ID: 37695905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA vaccine elicits an efficient antitumor response by targeting the mutant Kras in a transgenic mouse lung cancer model.
    Weng TY; Yen MC; Huang CT; Hung JJ; Chen YL; Chen WC; Wang CY; Chang JY; Lai MD
    Gene Ther; 2014 Oct; 21(10):888-96. PubMed ID: 25077772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lentiviral-based approach for the validation of cancer therapeutic targets in vivo.
    Ambrogio C; Stern P; Scuoppo C; Kranz H; Barbacid M; Santamaría D
    Biotechniques; 2014 Oct; 57(4):179, 181-7. PubMed ID: 25312087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic tumor suppression by coexpression of FUS1 and p53 is associated with down-regulation of murine double minute-2 and activation of the apoptotic protease-activating factor 1-dependent apoptotic pathway in human non-small cell lung cancer cells.
    Deng WG; Kawashima H; Wu G; Jayachandran G; Xu K; Minna JD; Roth JA; Ji L
    Cancer Res; 2007 Jan; 67(2):709-17. PubMed ID: 17234782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isoform-Specific Effects of Wild-Type Ras Genes on Carcinogen-Induced Lung Tumorigenesis in Mice.
    Weyandt JD; Carney JM; Pavlisko EN; Xu M; Counter CM
    PLoS One; 2016; 11(12):e0167205. PubMed ID: 27911940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-throughput detection of clinically relevant mutations in archived tumor samples by multiplexed PCR and next-generation sequencing.
    Bourgon R; Lu S; Yan Y; Lackner MR; Wang W; Weigman V; Wang D; Guan Y; Ryner L; Koeppen H; Patel R; Hampton GM; Amler LC; Wang Y
    Clin Cancer Res; 2014 Apr; 20(8):2080-91. PubMed ID: 24573554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Scrib heterozygosity predisposes to lung cancer and cooperates with KRas hyperactivation to accelerate lung cancer progression in vivo.
    Elsum IA; Yates LL; Pearson HB; Phesse TJ; Long F; O'Donoghue R; Ernst M; Cullinane C; Humbert PO
    Oncogene; 2014 Nov; 33(48):5523-33. PubMed ID: 24276238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of SLC22A18 as a tumor suppressor and novel biomarker in colorectal cancer.
    Jung Y; Jun Y; Lee HY; Kim S; Jung Y; Keum J; Lee YS; Cho YB; Lee S; Kim J
    Oncotarget; 2015 Sep; 6(28):25368-80. PubMed ID: 26196590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of RBM5 induces autophagy in human lung adenocarcinoma cells.
    Su Z; Wang K; Li R; Yin J; Hao Y; Lv X; Li J; Zhao L; Du Y; Li P; Zhang J
    World J Surg Oncol; 2016 Feb; 14():57. PubMed ID: 26923134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.